Author:
Li Jiangfan,Tan Yan,Li Kexin,Hui Ai-Min,Wu Zhuli,Han Pu,Wei Zhen,Qiu Jingjun,Diao Lei,Wang Xuhong
Funder
Shanghai Fosun Pharmaceutical Development Co., Ltd.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference26 articles.
1. Yaeger R, Corcoran RB. Targeting Alterations in the RAF-MEK Pathway. Cancer Discov. 2019;9(3):329–41. https://doi.org/10.1158/2159-8290.CD-18-1321.
2. Linares MA, Zakaria A, Nizran P. Skin cancer. Prim Care. 2015;42(4):645–59. https://doi.org/10.1016/j.pop.2015.07.006.
3. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. https://doi.org/10.3322/caac.21654.
4. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949–54. https://doi.org/10.1038/nature00766.
5. BioPharma A. Mektovi (binimetinib) US Prescribing Information (January 2019) [June 2022]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210498s001lbl.pdf.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献